ReviewJournal of thoracic disease2022

Neoadjuvant immunotherapy in non-small cell lung cancer: a narrative review on mechanisms, efficacy and safety.

Lan Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.